Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.
Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.
Address: Top Floor, 111 Rathmines Road Lr, Dublin 6
Tel: 353 (01) 441 0024
GreenCross Publishing is owned by Graham Cooke.
Payments made by the HSE Primary Care Reimbursement Service (PCRS) in 2020 rose by more than €300 million due to costs related to the pandemic.
The PCRS issued €3.3 billion in payments and reimbursements last year compared to just over €3 billion in 2019.
More than €168 million in Covid-19 emergency costs were issued in 2020, while more people became eligible for medical and GP visit cards, among other schemes, as the pandemic led to widespread job losses.
The payment data was revealed in the PCRS Statistical Analysis of Claims and Payments 2020 report, recently published on the HSE website.
The report revealed a rise in the number of individuals eligible for the general medical services (GMS) scheme following a decline over several years.
Around €788 million was paid in GP fees and allowances last year, representing an increase of almost €200 million in payments compared to 2019, when €589 million was expended.
The 2020 GP payment figures included €120,000 towards a GP investment development fund. However, a breakdown of payments to GPs showed that general practice received almost twice that amount in development funding in 2019, when €310,000 was issued.
Payments to pharmacists also increased last year, totalling €1.395 billion compared to approximately €1.326 billion in 2019.
Expenditure on drugs and medicines came to €985 million last year, while pharmacists were paid €382 million in fees and stock order mark-ups.
Pharmacist patient care fees amounted to €28 million, a rise of €3 million. Spending on high tech drugs and medicines also increased from €849 million in 2019 to €916 million last year.
Meanwhile, fees paid to dentists, optometrists and ophthalmologists fell as administration costs increased.
Spending on hospital oncology drugs and medicines increased by €14 million to €82 million, but hepatitis C drugs and medicines expenditure more than halved, with €22 million spent in 2020.
Due to new reimbursement rules, around €12 million was spent on multiple sclerosis medicines last year.
HIQA will be examining ‘transitions of care’ as part of its revised methodology for monitoring...
Tallaght University Hospital (TUH) has deployed a new electronic patient record (EPR)...
The ICGP is examining alternative pathways for entry into general practice training as part of efforts...
In December, the HSE released part of an external review into the case of 'Brandon', a...
The evidence on doctor burnout “should scare us and concern us”, the Director of the RCSI...
A review of public health governance structures and addressing “longstanding” IT infrastructure...
Leave a Reply
You must be logged in to post a comment.